Exact Sciences Corporation (EXAS) financial statements (2020 and earlier)

Company profile

Business Address 441 CHARMANY DRIVE
MADISON, WI 53719
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3241,1611,2391,2831,1241,1851,222
Cash and cash equivalents 1,034205285160162226
Short-term investments21261,0349989641,024997
Other undisclosed cash, cash equivalents, and short-term investments322      
Receivables131826456444236
Inventory, net of allowances, customer advances and progress billings62544844393935
Inventory62544844393935
Other undisclosed current assets41242424202416
Total current assets:5571,3201,3751,4071,2281,2901,310
Noncurrent Assets
Operating lease, right-of-use asset126   
Property, plant and equipment455371335292245188140
Intangible assets, net (including goodwill), including:2,347444546462223
Goodwill1,2031717171722
Intangible assets, net (excluding goodwill)1,144272728292121
Other undisclosed intangible assets, net (including goodwill) 0000  
Other noncurrent assets20242726499
Total noncurrent assets:2,949439407363296220172
TOTAL ASSETS:3,5061,7591,7821,7711,5241,5101,483
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21915417116112910271
Accounts payable26192018283311
Accrued liabilities1931351511431016960
Debt931631200 5
Contract with customer, liability011 
Other liabilities8976333
Other undisclosed current liabilities 131414
Total current liabilities:23648149216813710783
Noncurrent Liabilities
Long-term debt and lease obligation1435014942524171
Long-term debt, excluding current maturities245014942524171
Operating lease, liability119   
Liabilities, other than long-term debt35303079137
Other liabilities35303079137
Other undisclosed noncurrent liabilities804  794673656648
Total noncurrent liabilities:981530524826706686655
Total liabilities:1,2181,0111,016994843793738
Stockholders' equity
Stockholders' equity attributable to parent2,288748766777681717744
Common stock1111111
Additional paid in capital3,4061,9451,9201,8941,7171,6991,681
Accumulated other comprehensive income (loss)(0)(0)20(1)(1)(2)
Accumulated deficit(1,120)(1,198)(1,157)(1,119)(1,036)(982)(936)
Total stockholders' equity:2,288748766777681717744
TOTAL LIABILITIES AND EQUITY:3,5061,7591,7821,7711,5241,5101,483

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues296219200162143118103
Cost of revenue(69)(53)(52)(43)(38)(30)(27)
Gross profit:2261661481191058876
Operating expenses(323)(202)(182)(187)(154)(129)(109)
Operating loss:(96)(36)(34)(68)(49)(41)(33)
Nonoperating expense(11)(4)(5)(15)(5)(4)(4)
Investment income, nonoperating3987665
Interest and debt expense(14)(13)(13) (1)  
Loss from continuing operations before equity method investments, income taxes:(120)(53)(52)(84)(55)(45)(36)
Other undisclosed income from continuing operations before income taxes141313 1  
Loss from continuing operations before income taxes:(107)(40)(39)(84)(54)(45)(36)
Income tax expense (benefit)185(1)00(0)(0)0
Net income (loss) available to common stockholders, diluted:78(40)(38)(83)(54)(45)(36)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income (loss):78(40)(38)(83)(54)(45)(36)
Other comprehensive income (loss)21(0)(1)(0)  
Comprehensive income (loss):80(40)(39)(84)(54)(45)(36)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)(3)22000
Comprehensive income (loss), net of tax, attributable to parent:78(43)(37)(81)(54)(45)(36)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: